Risk factors
Tonix Pharmaceuticals Holding (TNXP) risk factors
Item 1A of every Tonix Pharmaceuticals Holding Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors68 risks16 new11 dropped9 reworded
Tonix is transitioning from a clinical-stage company to a commercial organization following the August 2025 FDA approval of TONMYA for fibromyalgia.
Filed Mar 12, 2026 - FY2024 10-K risk factors63 risks
Cash runway extends only into the first quarter of 2026, creating a going concern risk.
Filed Mar 18, 2025